Hi [[ session.user.profile.firstName ]]

Transformational Health

  • Date
  • Rating
  • Views
  • Future of Clinical Laboratories—Winning Strategies & Growth Opportunities
    Future of Clinical Laboratories—Winning Strategies & Growth Opportunities
    Divyaa Ravishankar, Industry Principal,Frost & Sullivan, Kyle Fetter, Executive Vice President, XIFIN Recorded: Mar 5 2019 64 mins
    What are the winning strategies for a laboratory to be successful? This webinar will focus on the state of the clinical laboratories market in the US, Canada, and Europe. Given the reimbursement cuts, it is essential to understand how this can impact the revenue-generating abilities of clinical laboratories and what strategies they can take now to keep the business profitable.

    Frost & Sullivan invites you to join Divyaa Ravishankar, Industry Principal, Frost & Sullivan and Kyle Fetter, Executive Vice President & General Manager of Diagnostic Services, XIFIN, for the webinar: Future of Clinical Laboratories—Winning Strategies & Emerging Growth Opportunities. The event will provide an overview of the current state of clinical laboratories and recommendations for future success followed by an interactive, live question-and-answer session.

    Key Takeaways:

    • Understand what is driving business for clinical laboratories and what will change in the future
    • Learn how are clinical laboratories adjusting to the declining reimbursement situation
    • Gain insight on ways a data-driven approach can help laboratories increase efficiency
    • Better understand how blockchain applies in the world of clinical laboratory services testing
  • 2019 Life Science Predictions: Decoding 5 Incredible Growth Opportunities
    2019 Life Science Predictions: Decoding 5 Incredible Growth Opportunities
    Nitin Naik, Unmesh Lal, Khushbu Jain, Fred Mao, Barbara Gilmore, Frost & Sullivan Recorded: Feb 6 2019 74 mins
    The Life Science industry is in a state of flux. While recent years have seen the advent of multiple novel technologies—such as IVF, CRISPR-Cas9, virtual clinical trials, and liquid biopsy—the industry today stands at a crossroads with challenges in scaling up and commercializing such technologies. The industry has now come to terms with new, path-breaking life science technologies that are helping make precision healthcare a reality. Chinese investments into the US biopharma industry jumped to $4.5 billion in 2018. An exclusive fireside chat with our US and China analysts will uncover trends in cross-border investments and growth opportunities in these two markets.

    Key Takeaways:

    • Establish the leading factors that will influence the size and direction of the global life sciences market in 2019.
    • Build clarity on technology developments in the global life sciences market in 2018 that will have an impact during 2019.
    • Identify the business models used to commercialize and distribute novel life science solutions.
    • Discover the key growth opportunities and strategic imperatives for companies in 2019.
  • 2019 Healthcare Predictions – Growth Opportunities, Technology, and Trends
    2019 Healthcare Predictions – Growth Opportunities, Technology, and Trends
    Reenita Das, Partner and Senior Vice President, Kamaljit Behera, Industry Analyst, Transformational Healthcare Recorded: Nov 8 2018 72 mins
    In 2019, digital health will come of age. Favorable reimbursement policies for clinically relevant digital health applications will expand care delivery models beyond physical medicine. 2019 will be a reality check for two of the most hyped healthcare technologies of this decade—Artificial Intelligence (AI) and Blockchain.

    Globally, 2019 will be a year of value-based care as we expect the outcomes-based care focus to globalize. Access to affordable and quality care will be a key political agenda for upcoming elections in emerging markets such as Asia, Africa, and Central and Eastern European countries. Non-traditional players with digital technologies, such as Amazon, Ali Health, Microsoft and IBM, will provide the required impetus to public health systems to ensure accessibility and affordability of care.

    Key Takeaways:
    • Learn how many of our 2018 predictions came true
    • Gain insight into the critical issues affecting the healthcare industry globally
    • Identify new opportunities connected to the pharmaceutical, biotechnology, medical technologies, diagnostics, and healthcare IT sectors
  • Medical Marijuana Market Trends—Future Clinical Role of Medical Marijuana & CBD
    Medical Marijuana Market Trends—Future Clinical Role of Medical Marijuana & CBD
    Nitin Naik (Moderator) Barbara Gilmore, Senior Consultant, Frost & Sullivan, Dr. Joseph C. Maroon, University of Pittsburgh Recorded: Oct 30 2018 48 mins
    Medical cannabis use is driving industry revenues into the billions. Investments by pharmaceutical and Big Tobacco companies in the development of cannabis and CBD-based products and devices, along with healthcare-conscious consumers having access to these products, are spurring growth. Physicians, aware of increasingly widespread medical marijuana legalization, are interested in understanding the potential of these treatments. In US states where cannabis is approved, the use of prescription drugs, including the use of opioids, has decreased.

    Key Takeaways:
    • Learn about a variety of medical marijuana science and clinical uses/applications (patient experiences)
    • Discover health-related applications of medical marijuana based on interactions with the endocannabinoid system
    • Explore the latest clinical research in cancer, neurological, psychological, metabolic and pain disorders using medical marijuana
  • New Commercialization and Revenue Strategies for Medical Technology Companies
    New Commercialization and Revenue Strategies for Medical Technology Companies
    Charlie Whelan, Vice President of Consulting, Transformational Health, Frost & Sullivan Recorded: Oct 9 2018 61 mins
    In a market where products are increasingly commoditized and healthcare providers are being rewarded for outcomes, medical technology companies must realign their current and future business models to account for disruptive forces in the industry. Companies that have historically competed based on engineering skill and clinical evidence are finding new sources of innovation and value creation. Many medical device companies still struggle to unlock this value and find effective ways to partner with their healthcare customers. Firms that fail to capture this opportunity will fall further behind competitors who are creating revenue streams built on delivering outcomes supported by data-empowered services.
  • Conquering Aging: Novel Technology Disruptions in the Anti-Aging Industry
    Conquering Aging: Novel Technology Disruptions in the Anti-Aging Industry
    Frost & Sullivan's Global Transformational Health Experts, Insilico Medicine, ChromaDex, Dthera Sciences Recorded: Sep 18 2018 70 mins
    The anti-aging industry is moving toward a “prevent-manage-repair” continuum that is creating novel market opportunities such as pharmacological targeting of aging, the “drug-as-a-service” business model, the use of digital pills to track drug consumption and adherence, and digital therapies that will help lower costs and reduce side effects.

    Key Takeaways:
    • Discover innovations in anti-aging drugs and therapies, novel nutrition, and digital tools
    • Engage with thought leaders to understand the dynamics around significant market trends, innovative business models, and game-changing companies.
    • Uncover key investment opportunities and growth potential.
  • How MedTech Will Accelerate the Smart Home Billion-Dollar Market & Revamp Care
    How MedTech Will Accelerate the Smart Home Billion-Dollar Market & Revamp Care
    Sowmya Rajagopalan, Global Program Director, Siddharth Shah, Industry Analyst, Transformational Health, Frost & Sullivan Recorded: Aug 30 2018 59 mins
    Healthcare delivery is moving away from traditional healthcare centers such as hospitals and clinics. Other non-traditional areas are becoming centers for healthcare delivery to provide more urgent, convenient and cost-effective care. This path ends at home—where a patient spends the most time, is most comfortable and can recover best. This area provides opportunities for much more than just care delivery. Homes, if enabled with the right care equipment, devices, and technology, can serve not only patient screening, monitoring, and disease management, but also health and wellness monitoring opportunities. Several companies have already recognized this trend and, along with startups, are targeting it to capitalize early.
  • The Impact of Artificial Intelligence in Medical Imaging
    The Impact of Artificial Intelligence in Medical Imaging
    Nadim Daher,Industry Principal, Siddharth Shah, Industry Analyst, Frost & Sullivan's Global Transformational Health Recorded: Aug 9 2018 56 mins
    Medical imaging has become a leader for the application of artificial intelligence technologies in the healthcare space, especially recently with deep learning techniques. This is evident from the fact that over 90 companies have set out to develop and commercialize AI-based solutions for the medical imaging industry. The number continues to grow as new start-ups emerge, as incumbents develop native AI solutions, and as tech companies move into the field, creating a highly dynamic ecosystem. With various countries edging past the innovator adoption phase and into the early adopter one, the time is now for stakeholders to refine and test their value proposition, partnership approach, and go-to-market strategies.

    Key Takeaways:
    • How far we have reached over the past five years and the current lay of the land
    • Where we are headed over the next five years and the direction of industry progress
    • Deep-dive into the opportunity for automation, acceleration and augmentation of medical image analysis
    • Anticipate the advent of intelligent medical imaging machines with embedded AI
  • Digital Therapeutics: Trends and Growth Opportunities
    Digital Therapeutics: Trends and Growth Opportunities
    Frost & Sullivan's Global Digital Health Team, Wolf Shlagman CEO - Care Angel, Amer Haider CEO - Doctella Recorded: Jun 26 2018 61 mins
    Digital therapeutics presents a significant opportunity for traditional pharmaceutical therapeutics and information technology (IT) capabilities to influence a new approach to increase positive patient outcomes while reducing the overall cost of healthcare.

    Key Takeaways:
    · Gain expert insight into the accurate definition of digital therapeutics and market participants.
    · Learn about new solutions from mHealth companies that will combine apps, patient education, professional intervention and peer support to increase patient engagement and medication adherence by augmenting or replacing traditional drug therapeutics.
    · Hear opportunities to utilize digital therapeutics to improve medical workflow and patient communications.
    · Learn about some of the critical milestones related to digital therapeutics.
  • The Rise of Digital Enterprise: Growth Strategies for Healthcare Companies
    The Rise of Digital Enterprise: Growth Strategies for Healthcare Companies
    Nitin Naik, Slava Akmaev Chief Analytics Officer, BERG, Guillaume Kerboul, Dassault Systemes; Dr. Thorsten Harzer, QIAGEN Recorded: May 31 2018 59 mins
    Digital Transformation is powering growth opportunities in Smart R&D, Patient Engagement, and Healthcare eCommerce. The explosion of patient centricity and technological advancement in big data analytics, cloud and artificial intelligence are putting severe pressures on companies to leverage all types of data (clinical, social media, IOT, etc.) in innovative ways. While the industry is decidedly upbeat on this new trajectory, there are heightened concerns about managing data privacy, especially for data flows outside the traditional ecosystem.

    Key Takeaways:
    • Learn about trends and growth opportunities in the Life sciences IT sector
    • Discuss hot topics, including Smart R&D, Digital Manufacturing, Connected patient and IVD eCommerce (B2C models)
    • Hear from industry leaders about company growth strategies and best practices for implementing digital solutions
    • Gain perspectives on M&A’s and the impact of investments from Big Tech companies

Embed in website or blog